The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.

Attorney General Keith Ellison announced a settlement with Novo Nordisk that let's Minnesotans buy its insulin products for ...

This has meant that Tresiba has got off to a slower start than hoped in the US following approval in late 2015, where it must also compete against Sanofi’s next generation long-acting insulin ...

The approval covers all 27 European Union member states. Tresiba (insulin degludec) is a once-daily new-generation based insulin analogue with an ultra-long duration of action. Ryzodeg (insulin ...

Now, providers will have to determine which other insulin brand is preferred during pregnancy. Tresiba (insulin degludec), a longer-acting insulin, has been shown to be safe and effective in ...

There are currently shortages of the Tresiba FlexTouch insulin pen which could affect people living with diabetes who take Tresiba insulin. Here’s what you need to know.

Minnesotans prescribed insulin won’t pay more than $35 per month for it, after the conclusion of a lawsuit against three ...

The list prices of its insulin drug Fiasp will be reduced by 75%, while the list prices of its Tresiba insulin will be reduced by 72.2%, Novo said in a statement. As a result, Novo will discontinue ...